Earnings Ahead

AEZS - AEterna Zentaris Inc. (USA)

AEterna Zentaris Inc. (USA)

AEterna Zentaris Inc. (USA)

About

Profile


Headquarters


Intraday

High
-
Low
-

52-week

High
-
Low
-

AEZS



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Aeterna Zentaris files to sell 2.53M warrants
  • Aeterna Zentaris and Ceapro to merge in all-stock deal
  • Aeterna Zentaris GAAP EPS of -$0.85
  • Aeterna Zentaris GAAP EPS of -$0.52, revenue of $2.2M
  • Aeterna Zentaris GAAP EPS of -$0.88, revenue of $2.1M
  • Aeterna falls 13% after halting U.S. sales of lead product
  • Aeterna Zentaris GAAP EPS of -$2.56, revenue of $2.5M
  • Aeterna stock rises ~10% after Pharmanovia acquires rights to Ghryvelin in EU, UK
  • Aeterna Zentaris GAAP EPS of -$0.70 misses by $0.02, revenue of $1.9M beats by $0.57M
  • Aeterna Zentaris to regain full rights to Macrilen oral test from Novo Nordisk
  • Aeterna Zentaris GAAP EPS of -$0.87, revenue of $0.2M
  • Aeterna slips ~10% after announcing date of reverse stock split
  • Aeterna Zentaris licensing partner Consilient launches growth hormone deficiency test in Europe
  • Aeterna Zentaris GAAP EPS of -$0.02, revenue of $1.5M
  • Aeterna Zentaris gets European patent related to macimorelin to detect growth hormone deficiency
  • Aeterna Zentaris GAAP EPS of -$0.02 in-line, revenue of $1M beats by $0.37M
  • Aeterna Zentaris pivotal growth hormone deficiency trial sees recruitment delays
  • Aeterna Zentaris expands research program for COVID-19/Chlamydia vaccines
  • Aeterna Zentaris to get US patent for potential hormone disorder therapy AEZS-150
  • Aeterna Zentaris gets 180-day extension to comply with Nasdaq's minimum bid price rule

Earnings History

Date EPS / Forecast Revenue / Forecast
November 4, 2021 -0.01 / -0.02 602K / 615K
August 12, 2021 -0.06 / - - / -
May 5, 2021 -0.02 / - 586K / - Beat!
March 30, 2021 - / -0.11 - / 0.40M
May 7, 2018 0.87 / 0.59 24.66M / 13.06M Beat!
March 28, 2018 -0.03 / -0.31 178.0K / 0.13M Beat!
November 8, 2017 -0.61 / -0.26 241.0K / 0.12M Beat!
August 10, 2017 -0.18 / -0.38 243.0K / 0.22M Beat!
May 8, 2017 -0.31 / -0.30 261.0K / 0.11M Beat!
March 15, 2017 -0.97 / -0.73 304.0K / 0.40M Beat!
Date Price Open High Low Vol Change ER
Aug 10 6.550 6.180
6.670
6.180
2.92K 2.99%
Aug 9 6.360 6.400
6.400
6.360
0.50K 0.32%
Aug 8 6.340 6.260
6.340
6.240
0.31K -0.63%
Aug 5 6.380 6.100
6.415
6.100
4.24K 3.40%
Aug 4 6.170 6.480
7.400
5.980
21.65K -2.6%
 
Aug 3 6.335 5.950
7.000
5.900
10.75K 7.01%
Aug 2 5.920 5.740
5.920
5.740
3.67K 4.04%
Jul 29 5.690 5.730
5.730
5.540
3.99K -0.35%
Jul 28 5.710 5.610
5.990
5.610
3.01K -0.35%
Jul 27 5.730 5.530
5.730
5.500
2.85K 3.06%
Jul 26 5.560 5.690
5.690
5.500
4.36K -2.28%
Jul 25 5.690 6.300
6.300
5.620
6.51K -9.54%
Jul 22 6.290 5.660
6.290
5.530
6.04K 11.52%
Jul 21 5.640 6.080
6.250
5.500
14.23K -7.92%
Jul 20 6.125 6.375
6.750
6.125
5.15K -7.55%
Jul 19 6.625 6.750
6.750
6.250
3.41K -5.36%
Jul 18 7.000 7.000
7.500
7.000
4.30K -5.08%
Jul 15 7.375 7.250
7.625
7.125
1.71K 3.51%
Jul 14 7.125 7.250
7.250
7.125
1.20K -1.72%
Jul 13 7.250 7.000
7.250
7.000
0.60K -1.69%
Jul 12 7.375 7.375
7.375
7.375
0.02K 0%
Jul 11 7.375 7.875
7.875
7.375
0.29K 0%